IMMUNE-MEDIATED HEMOLYTIC ANEMIA IN A DOG – A CLINICAL CASE
The article describes a case of Immune-mediated hemolytic anemia in a dog. There is a description of the dynamic of the disease before and after the beginning of treatment with immunosuppressive drugs (Prednisolone and Azathioprine). The laboratory study shows significant improvement, the patient has no clinical complaints. There is a discussion for the approach to such clinical presentation and the application of a successful therapeutic strategy.
Al-Ghazlat S. (2009). Immunosuppressive Therapy for Canine Immune-Mediated Hemolytic Anemia. Compend Contin Educ Vet. 2009 Jan;31(1):33–41, 44; quiz 44.
Balch A., Mackin A. (2007). Canine Immune-Mediated Hemolytic Anemia: Pathophysiology, Clinical Signs, and Diagnosis. Compendium (Yardley, PA), 217–225
Barcellini W. (2015). New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia. Transfus Med Hemother. Sep; 42(5):287-93. doi: 10.1159/000439002. Epub 2015 Sep 7.
Cohn L. (1991). Journal of Veterinary Internal Medicine. Vol. 5. No. 2., 95–104.
Mackin, A. (2014). Immune-mediated hemolytic anemia: pathophysiology and diagnosis. DVAVM, 1–54
Pedersen. N. (1999). A review of immunologic diseases of the dog. Veterinary Immunology and Immunopathology, 69 (1999) 251–342
Piek, C. (2011). Canine idiopathic immune-mediated haemolytic anaemia: a review with recommendations for future research. Veterinary Quarterly, 31:3, 129–141
Scott-Moncrieff J., Treadwell N., McCullough S., Brooks M. (2001). Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J. Am. Anim. Hosp. Assoc. 37, 220–227.
Thrall M., Weiser G., Allison R., Campbell T. (2012). Veterinary Hematology and Clinical Chemistry. Second Edition, pp. 87–114.
Weinkle T., Center S., Randolph J. (2005). Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993–2002). JAVMA; 226(11):1869–1880.